Table 3.
Summary of the main characteristics of patients (with TINF2 mutations) in this study group compared with patients with DC in general
| Clinical feature | No. index patients in this study | Percentage of patients in this study | Percentage of patients reported in DC16 |
|---|---|---|---|
| AA at any age | 32 | 97 | 86 |
| AA at < 10 y | 21 | 63 | 51 |
| Nail dystrophy | 29 | 88 | 88 |
| Abnormal skin pigmentation | 19 | 58 | 89 |
| Leukoplakia | 19 | 58 | 78 |
| Classical triad | 12 | 36 | NA |
| Features of HH | 6 | 18 | NA |
| Osteoporosis | 6 | 18 | NA |
| Retinopathy (Revesz syndrome) | 4 | 12 | NA |
Classical triad indicates combination of nail dystrophy, abnormal skin pigmentation, and leukoplakia; NA, data not available.